Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

Journal of Endocrinological Investigation

Volumn 24, Issue 2, 2001, Pages 67-71

  Gianotti, L ^a   Ramunni, J ^a   Lanfranco, F ^a   Maccagno, B ^a   Giordano, R ^a   Broglio, F ^a   Maccario, M ^a   Muller, E E ^b   Ghigo, E ^a   Arvat, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ACTH; Cortisol; GH; GH secretagogues; hCRH; Hexarelin; Humans; rhlGF I

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOSE; GROWTH HORMONE; HEXARELIN; HYDROCORTISONE; IBUTAMOREN; INSULIN; PLACEBO; RECOMBINANT SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHIBITION KINETICS; INJECTION PAIN; INJECTION SITE; NEGATIVE FEEDBACK; NORMAL HUMAN;

ADRENOCORTICOTROPIC HORMONE; ADULT; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; KINETICS; OLIGOPEPTIDES; PLACEBOS; RECOMBINANT PROTEINS;

EID: 0035095248     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343815     Document Type: Article

References (28)

1. Effects of dexamethasone on GHRH, arginine and dopamine stimulated GH secretion and total plasma IGF-I concentrations in normal male volunteers
2. Effect of a short-term treatment with recombinant growth hormone (GH) on adrenal responsiveness to corticotrophin stimulation in children affected by isolated GH deficiency
3. Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD
4. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers
5. Effects of acute and repeated intravenous administration of L-692, 585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin and thyroxine levels in beagles
6. Repeat administration on the growth hormone secretagogue MK-0677 increase a and maintains elevated IGF-I levels in beagles
7. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins
8. Somatomedin production by rat liver in organ culture, Part 3. Studies on the release of insulin-like growth factor and its carrier protein measured by radioligand assays. Effects of growth hormone, insulin and cortisol
9. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat
10. Dexamethasone increases hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat
11. Physiology of growth hormone secretion and action
12. Insulin-like growth factors and their binding proteins
13. Growth hormone axis in Cushing's syndrome
14. Role of glucocorticoids in the neuroregulation of growth hormone secretion
15. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
16. The effect of six months treatment with a 100 mg daily dose of DHEA on circulating sex steroids, body composition and muscle strength in age-advanced men and women
17. Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men
18. Peptidomimetic regulation of growth hormone secretion
19. The GH, PRL, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations
20. Hormonal activities of growth hormone secretagogues (GHS) across human lifespan
21. Increases in circulating insulin-like growth factor-I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation
22. The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers
23. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or Hexarelin, a peptidyl GH secretagogue, in humans
24. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary
25. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: Evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II
26. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat
27. Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release
28. Growth hormone-releasing peptides